ѰҽÎÊÒ©Íø > ¹ØÓÚµ°°×¼¤Ã¸CÓëÖÜΧÉñ¾­ÔÙÉúµÄÎÊÌâ

¹ØÓÚµ°°×¼¤Ã¸CÓëÖÜΧÉñ¾­ÔÙÉúµÄÎÊÌâ

ÎÄ·¢²¼Õߣº
À´Ô´£ºÑ°Ò½ÎÊÒ©Íø
¹ØÓÚµ°°×¼¤Ã¸CÓëÖÜΧÉñ¾­ÔÙÉúµÄÔ­Òò,¹ØÓÚµ°°×¼¤Ã¸CÓëÖÜΧÉñ¾­ÔÙÉúµÄÏà¹ØÖªÊ¶¡£     ÑîÆ¼ 2004-7-31 21:36:00 µÚÈý¾üÒ½´óѧѧ±¨1999ÄêµÚ21¾íµÚ12ÆÚ

    Ëæ×Åϸ°ûÉúÎïѧºÍ·Ö×ÓÉúÎïѧµÄ·ÉËÙ·¢Õ¹,ÖÜΧÉñ¾­(Peripheral nerve,PN)ÔÙÉúµÄÑо¿ÖصãÒÑ´Ó80Äê´ú²ÉÓÃÏÔ΢Íâ¿Æ¼¼Êõ¼ÓÇ¿Éñ¾­ÐÞ¸´Ê±µÄ¾«Ï¸²Ù×÷Öð½¥×ªÒƵ½Ì½ÌÖµ÷½ÚÉñ¾­ÔÙÉúµÄ¾Ö²¿»òÕûÌåµÄÉúÎïѧÒòËØ¡£ÆäÖÐ,Éñ¾­ÔÙÉúµÄϸ°ûÄÚµ÷½Ú»úÖÆÒýÆðÁËÈËÃǼ«´óµÄ¹Ø×¢¡£Ï¸°ûÄÚÉúÎïÐÅÏ¢´«µÝϵͳÊǽéÓÚ¸÷ÖÖϸ°ûÍâÓ°ÏìÒòËØÓëϸ°û²úÉúÔÙÉúЧӦ֮¼äµÄÇÅÁº,Éæ¼°¶à¸öÖØÒªµÄ»·½Ú,µ°°×¼¤Ã¸C(Protein kinase C,PKC)¾ÍÊÇÆäÖÐÖ®Ò»£¬Ëüͨ¹ýÓ°Ïì¶àÖÖµ°°×Öʵ×ÎïÁ×Ëữ,²ÎÓëһϵÁÐÓëÉúÃüÏÖÏóÓйصĹý³Ì£¬Èç²ÎÓëϸ°ûÐźŴ«µÝ£¬¿ØÖÆÏ¸°ûÔöÖ³Óë·Ö»¯£¬µ÷½Ú»ùÒò±í´ï£¬¸Ä±äϸ°ûÐÎ̬£¬²ÎÓëÉñ¾­µÝÖÊÊͷŵÈ[1]¡£½üÄêÀ´,²»ÉÙѧÕß¶ÔPKCÔÚPNÔÙÉú¹ý³ÌÖеÄ×÷ÓýøÐÐÁËÓÐÒâÒåµÄ̽ÌÖ¡£

    1 PKCÔÚÖÜΧÉñ¾­ÖеÄÕý³£·Ö²¼

    PKCÊÇNishizukaµÈÓÚ1977ÄêÊ״η¢ÏÖµÄ,¾­¹ý½ü20ÄêµÄÑо¿,Æù½ñΪֹÖÁÉÙÒѼø¶¨³ö12ÖÖÑÇÐÍ£¬¸ù¾ÝÆä½á¹¹¼°¸¨ÖúÒò×ӵIJ»Í¬,ͨ³£½«PKC·Ö³É3´óÀà,¼´µäÐ͵ÄPKCs(¦Á,¦Â¢ñ,¦Â¢ò,¦Ã),ÐÂPKCs(¦Ä,¦Å,¦Ç,¦È,¦Ì)ºÍ·ÇµäÐÍPKCs(¦Æ,¦Ë,¦É)[1£¬2]¡£PKCµÄÕâЩÑÇÐͳýÁËÔڽṹÉÏÓвîÒìÍâ,ÔÚϸ°ûºÍÑÇϸ°û·Ö²¼ÉÏ¡¢µ×ÎïÌØÒìÐÔ¡¢¶Ô¼¤»îÐźŵÄÃô¸ÐÐÔÒÔ¼°¶Ôϵ÷µÄÒ׸ÐÐԵȷ½Ãæ¶¼ÓÐËù²»Í¬£¬Òò´Ë,ËüÃÇÓи÷×ÔÌØÊâµÄ¹¦ÄÜ¡£Miki[3]²ÉÓÃÃâÒß×黯µÄ·½·¨±È½ÏÁË´óÊó¼¹Ëè¾±¶ÎÔ˶¯Éñ¾­Ôª×ÔÅßÌ¥µÚ13ÌìÖÁÉúºó7ÖܦÁ¡¢¦Â¡¢¦Ã3ÖÖCa2+-ÒÀÀµÐÍPKCs·Ö²¼µÄ¶¯Ì¬±ä»¯,·¢ÏÖ£ºÔÚÅßÌ¥µÚ13Ìì,¸Õ´ÓÉñ¾­ÉÏÆ¤·Ö»¯³öÀ´µÄÔ˶¯Éñ¾­ÔªÏ¸°ûºËÖÜΧ¡¢Ê÷Í»ºÍÖáÍ»ÄÚ¾ùÓЦÁ-¡¢¦Â-¡¢¦Ã-PKC3ÖÖÑÇÐÍ·Ö²¼,ÇÒø»îÐÔ·´Ó¦³Ì¶ÈÏàËÆ£»ÒÔºó,ºËÖܵÄPKCÖð½¥¼õÉÙ,°û½¬¡¢Ê÷Í»¡¢ÖáÍ»ÖÐ3ÖÖPKCÑÇÐ͵ıí´ï¸÷×Ô·¢Éú²»Í¬µÄ±ä»¯£»ÔÚÉúºóµÚ28¡«35Ìì,ÖáÍ»ÖÐÖ÷ҪΪ¦Â-PKC,ÔÚºËÖܰûÖʼ°Ï¸°ûÍ»ÆðÖЦÃ-PKC·Ö²¼ºÜÉÙ¡£Õâ¸ö½×¶ÎPKCµÄ·Ö²¼Óë³ÉÄêʱÆÚ¼¸ºõÏàͬ¡£PKCÕâ3ÖÖÑÇÐÍÔÚÔ˶¯Éñ¾­ÔªÉú³¤ÆÚºÍ³ÉÊìÆÚµÄ²»Í¬·Ö²¼,±íÃ÷PKC¿ÉÄܲÎÓëÉñ¾­ÔªÐÎ̬ºÍ¹¦ÄÜ·Ö»¯µÄ²»Í¬·½Ãæ,ÆäÔÚºËÖÜ·Ö²¼µÄ±ä»¯Ò²¿ÉÄÜÌáʾPKC²ÎÓëµ÷½ÚÉñ¾­ÔªÏ¸°ûºËµÄ¹¦ÄÜ¡£OkajimaµÈ[4]ÓÃͬÑùµÄ·½·¨Ñо¿ÁËÕý³£Éñ¾­ÏËάÖЦÁ¡¢¦Â¡¢¦Ã-PKCµÄ·Ö²¼,·¢ÏÖÕâ3ÖÖÑÇÐÍÔÚÕý³£ÓÐËèºÍÎÞËèÉñ¾­ÏËάÖж¼´æÔÚ£¬ÔÚÓÐËèÉñ¾­ÏËάÖÐ,ËüÃÇÖ÷Òª·Ö²¼ÔÚÖὬ»¬ÃæÄÚÖÊÍøÉÏ,ҲɢÔÚÓÚÖáĤÏÂ,µ«ÔÚ΢¹Ü¡¢Î¢Ë¿µÈϸ°û¹Ç¼ÜÇøÈ±·¦£»ÔÚÎÞËèÉñ¾­ÏËάÖÐ,PKCÃÖÉ¢·Ö²¼ÓÚÕû¸öÖὬ¡£KawanoµÈ[5]Ñо¿·¢ÏÖ£ºÕý³£Éñ¾­ÏËάÖЦġ¢¦Å¡¢¦Æ3ÖÖCa2+-·ÇÒÀÀµÐÍPKCsÑÇÐÍͬÑù´æÔÚ£¬ËüÃdzʿé×´·Ö²¼ÓÚÖὬÖв¢²»Á¬ÐøµØ·Ö²¼ÓÚÖáĤÏ¡£

    2 PKCÓëÖÜΧÉñ¾­ÔÙÉúµÄ¹ØÏµ

    ÓÉÓÚPKCÔÚϸ°ûÖÐÖØÒªµÄÉúÎïѧ×÷ÓÃ,²¢ÇÒÔÚPNÖзֲ¼¹ã·º,Òò´Ë,½üЩÄêÀ´,PKCÓëPNÔÙÉúµÄ¹ØÏµÒÑÒýÆðÈËÃǵÄ×¢Òâ¡£ÓÐÑо¿±íÃ÷[4£¬5],ÔÚ´óÊó×ø¹ÇÉñ¾­ËðÉ˺óµÄÔÙÉú¹ý³ÌÖÐ,Ca2+-ÒÀÀµÐÍPKCs(¦Á¡¢¦Â¡¢¦Ã)ºÍCa2+-·ÇÒÀÀµÐÍPKCs(¦Ä¡¢¦Å¡¢¦Æ)ÑÇÐ͹㷺·Ö²¼ÓÚÐÂÉúÖáÑ¿ÄÚ,ÇÒ»îÐÔÃ÷ÏÔÔöÇ¿£¬¶øµ±Éñ¾­ÔÙÉúÍê³ÉºóÆä±í´ïϵ÷¡£Óɴ˿ɼûPKCÔÚPNÔÙÉúÖпÉÄÜÓзdz£ÖØÒªµÄ×÷Óã¬Ëü¿ÉÄÜͨ¹ýÏÂÁлúÖÆ²ÎÓëPNÔÙÉú£º

    2.1 PKCÓ°ÏìÉú³¤×¶µÄÑÓÉì

    Éú³¤×¶ÊÇÄÜÒýÆðеİû½¬Í»Æð²¢ËæÖ®ÐγÉÖáÍ»µÄ½á¹¹,ËüÄܶÔÍâÀ´ÐźŽøÐÐÕûºÏ²¢×÷³öÊʵ±·´Ó¦¡£ÖáÍ»µÄÉú³¤·½ÏòÒÀÀµÓÚÉú³¤×¶ÓëÖÜΧ»·¾³È磺ϸ°ûÍâ»ùÖÊ(Extracellular matrix,ECM)ºÍϸ°ûÕ³Á¬·Ö×Ó(Cell adhesion molecular,CAMs)µÈµÄÏ໥×÷ÓÃ[6¡«8],¶øPKC¿ÉÄÜÔÚÉú³¤×¶µÄ»ý¼«ÑÓÉìÖз¢»ÓÖØÒªµÄ×÷Óá£Ê×ÏÈ,µ±ÖáÍ»ºÍÉú³¤×¶Ðγɺó,PKCµÄ¼¤»î¿Éά³ÖÉú³¤×¶µÄ˿״×ãºÍ°å×´×ã½á¹¹£¬·´Ö®,ÔòÆä×ã×´Í»Æð¿ìËÙ»ØËõ[9]¡£Æä´Î,PKCÔÚÉú³¤×¶ÑÓÉìʱËù±ØÐèµÄµ°°×ÖÊÁ×ËữÖÐÆð׏ؼüÐÔ×÷ÓÃ[10]¡£ÔÙ´Î,PKC´ÙʹÉñ¾­Óë²ãÕ³Á¬µ°°×(Laminin)Õ³Á¬,¼ÓÇ¿Éñ¾­¶ÔÉñ¾­Éú³¤Òò×Ó(NGF)µÄÓ¦´ð·´Ó¦,´Ó¶ø´Ù½øÉú³¤×¶µÄÑÓ³¤[4]¡£×îºó,Laminin´¥·¢µÄÉú³¤×¶µÄ·´Ó¦¿ÉÄÜÒÀÀµÓÚPKC¼¤»îµÄϸ°ûÄÚÐźŻúÖÆ[9]¡£

    2.2 PKC²ÎÓëGAP-43µÄÁ×Ëữ

    GAP-43(Growth associated protein-43)ÊÇÉñ¾­ÌØÒìÐԵĸƵ÷ËØÁ¬½Óµ°°×,ËüÊÇPKCÌØÒìÐԵĵ×ÎïÖ®Ò»,ÆäÁ×ËữÖ÷ÒªÓɦ¢ò-PKCµ÷¿Ø,Á×Ëữ·¢ÉúÔÚÆäµÚ41λ˿°±Ëá²Ð»ùÉÏ[8£¬11]¡£Á×ËữºÍ·ÇÁ×ËữµÄGAP-43¾ßÓв»Í¬µÄ¹¦ÄÜ:ǰÕßÖ±½Ó²ÎÓëÖáÍ»µÄÉú³¤ºÍÍ»´¥µÄÐγÉ,²¢´æÔÚÓÚÉú³¤×¶Äں㶨µÄÇøÓò£¬¶øºóÕßÓë¸Æµ÷ËØ½áºÏ,²¢×ÜÊÇ´æÔÚÓÚÍËËõµÄÉú³¤×¶ÖÐ[8£¬11]¡£´ËÍâ,2ÖÖÐÎʽµÄGAP-43¶ÔF-actin¾Û¼¯µÄÓ°ÏìÒ²²»ÍêÈ«Ïàͬ:Á×ËữµÄGAP-43ÓëF-actin¾ßÓиßÇ׺ÏÐÔ,Ö±½Óµ÷½ÚF-actinµÄ¾Û¼¯¶ø¸Ä±äÉú³¤×¶µÄ·½Ïò£»¶ø·ÇÁ×ËữµÄGAP-43ÔòÎÞ´Ë×÷ÓÃ[11]¡£Óɴ˿ɼû,GAP-43²ÎÓëµ÷½ÚÉñ¾­ÔÙÉúÖ÷Ҫȡ¾öÓÚPKCµÄ¹¦ÄÜ,Ö»Óб»PKCÁ×ËữÁ˵ÄGAP-43,²ÅÄÜ·¢»ÓÆä´Ù½øÉñ¾­ÔÙÉúµÄ×÷Óá£

    2.3 PKCµ÷½ÚÉñ¾­Ï¸°û¹Ç¼Ü³É·ÝµÄÁ×Ëữ

    ÖÜΧÉñ¾­ÔÙÉúµÄÌØµãÖ®Ò»ÊÇÖáÍ»×ÔÉíȱ·¦ºÏ³Éµ°°×µÄÄÜÁ¦,ÆäÔÙÉúËùÐèµÄ½á¹¹ºÍ¹¦ÄÜÎïÖÊÓɰûÌåºÏ³Éºó¾­¹ý³¤¾àÀëµÄתÔ˵½´ïÖáͻĩÉÒ,¶øµ£ÈδËÖØÒª¹¦ÄܵÄÎïÖÊÖ®Ò»ÊÇ΢¹Ü£¬Í¬Ê±ÖáÍ»µÄÐγɺ;¶ÏòÉú³¤Ò²Óë΢¹ÜÃÜÇÐÏà¹Ø[12]¡£´¦ÓÚ²»Í¬×´Ì¬µÄ΢¹Ü¾ßÓв»Í¬µÄ¹¦ÄÜ¡£Diaz-NidoµÈ[13]ÈÏΪ΢¹ÜµÄ¾Û¼¯ºÍÎȶ¨ÐÔµÄÔö¼ÓÊÇÖáÍ»³ÉÊìºÍά³ÖÐÎ×´Ëù±ØÐëµÄ,΢¹ÜµÄÔÝʱ½â¾Û¿ÉʹÖáÍ»¸Ä±äÐÎ×´¡£RosnerµÈ[10]Ò²Ìá³ö,¶¨ÏòµÄÖáÍ»ÑÓÉì¿ÉÄÜ»ùÓÚ΢¹ÜµÄÎȶ¨ºÍ¾Û¼¯³ÉÊø¡£Î¢¹ÜµÄ½â¾ÛºÍ¾Û¼¯ÓëÖáÍ»µÄÎȶ¨ÐԺͿÉËÜÐÔÖ®¼äµÄƽºâÓÉ΢¹ÜÏà¹ØÌǵ°°×(MAP)µÄÁ×Ëữ״̬À´µ÷½Ú,ÕâÀ൰°×°üÀ¨MAP-1A(350¡Á103u),MAP-1B(320¡Á103u),MAP-2(270¡Á103u)ºÍÒ»×é±»³Æ×ŦÃ-Òò×ӵĵ°°×ÖÊ,ËüÃǵÄÁ×Ëữ״̬Óɲ»Í¬µÄµ°°×¼¤Ã¸µ÷¿Ø¡£ÆäÖÐ,MAP-2µÄÁ×ËữÓëPKCÃÜÇÐÏà¹Ø¡£Á×ËữµÄMAP-2Ö÷Òª´æÔÚÓÚδ¾Û¼¯µÄ΢¹ÜÖÐ,²ÎÓë΢¹ÜµÄ½â¾Û,ÓÐÀûÓÚÍ»Æð¸Ä±äÐÎ×´ºÍ¿ÉËÜÐÔ·´Ó¦[12]¡£Ï¸°û¹Ç¼ÜµÄÁíÒ»Ö÷Òª³É·Ý¼¡¶¯µ°°×¿ØÖÆ×ÅÉú³¤×¶¶Ôϸ°ûÍâÐźŵķ´Ó¦,¼¡¶¯µ°°×Ë¿µÄ¾Û¼¯Êǵ÷½ÚÉú³¤×¶ÐÎ×´ºÍÔ˶¯µÄÖØÒª·½Ê½,ÓÉÁ×ËữµÄGAP-43µ÷¿Ø[8£¬11],ËùÒÔ,PKCÒ²¿ÉÒÔͨ¹ý¼ä½Ó×÷Ó÷½Ê½µ÷½Ú×Åϸ°û¹Ç¼ÜµÄ½á¹¹Ó빦ÄÜ¡£

    2.4 PKC´Ù½øSchwannϸ°ûÔöÉú

    Schwannϸ°ûÊÇPNµÄ½ºÖÊϸ°û,ÄܲúÉúºÍÊÍ·Å´óÁ¿ÓªÑøÒò×Ó,ÈçNGF¡¢ÄÔÔ´ÐÔÉñ¾­ÓªÑøÒò×Ó(BDTF)¡¢½Þ×´Éñ¾­ÓªÑøÒò×Ó(CNTF)¡¢ÖáÍ»Ç÷»¯Òò×Ó¡¢ÒÔ¼°CAM,ËèÇÊÏà¹ØÌǵ°°×(MAG)µÈ,ͬʱËü»¹Óкϳɡ¢·ÖÃں;ۼ¯ECM,Èç:LamininºÍ¢ñ¡¢¢ó¡¢¢ô¡¢¢õÐͽºÔ­µÄÄÜÁ¦¡£ÔÚÀëÌåʵÑéÖÐ,ÉÏÊöµ°°×ÖÊ·Ö×Ó¾ùÊÇÖáÍ»Éú³¤µÄ´Ù½ø¼Á,ÆäÖÐLamininµ÷½ÚÉñ¾­Í»ÆðÉú³¤µÄ×÷ÓÃ×îΪÏÔÖø[14]¡£Òò´Ë,Schwannϸ°ûÁ¼ºÃµÄ¹¦ÄÜ״̬ÊÇÖÜΧÉñ¾­³É¹¦ÔÙÉú±Ø²»¿ÉÉÙµÄÓ°ÏìÒòËØÖ®Ò»¡£PKCÓëSchwannϸ°ûµÄÔöÉú¹ØÏµÃÜÇÐ[4£¬15£¬16]¡£PNËðÉËÒÔºó,ËðÉ˾ֲ¿Schwannϸ°ûÄÚ¦Â-PKCµÄˮƽÉÏÉý,ÏÔʾ³öÇ¿ÁÒµÄÃâÒßÑôÐÔ·´Ó¦,²¢ÇÒPKCµÄ¼¤»î¿É´Ù½øËðÉ˾ֲ¿Schwannϸ°ûµÄÔöÉú[4]¡£YoshimuraµÈ[15]ÔÚÅàÑøµÄSchwannϸ°ûµÄ»ùÖÊÖмÓÈëÉñ¾­½ºÖÊϸ°ûÉú³¤Òò×Ó(GGF),·¢ÏÖSchwannϸ°ûÄÚPKCµÄ»îÐÔÔö¼Ó167%,ϸ°ûÄÚDAGµÄº¬Á¿Ôö¼Ó158%,ͬʱ,Schwannϸ°ûµÄ·ÖÁÑÔö¼Ó3±¶£»ÌرðÖµµÃÌá³öµÄÊÇ,GGFÓÕµ¼µÄSchwannϸ°ûÔöÖ³¿É±»PKCÒÖÖÆ¼ÁÒÔ¼ÁÁ¿ÒÀÀµµÄ·½Ê½ËùÒÖÖÆ¡£´ËÍâ,Schwannϸ°ûÁíһϸ°û·ÖÁÑËØ¡ªÑªÐ¡°åÔ´ÐÔÉú³¤Òò×Ó(PDGF)µÄÊÜÌå±»ÈÏΪÊÇÓëÁ×Ö¬õ£µ¨¼îË®½âÏà¹ØÁ¬,¹ÊPDGFÓÕµ¼µÄSchwannϸ°ûÔöÉú¿ÉÄÜÒ²ÊÇÓÉPKCÖнéµÄ¡£YamadaµÈ[16]ÔøÉè¼ÆÁËÒ»×é±»³ÆÎªTwitcherÊóµÄ¶¯ÎïÄ£ÐÍ£¬¸ÃʵÑ鶯ÎïÓÉÓÚȱ·¦°ëÈéÌÇÉñ¾­Çʰ±´¼Ã¸(Galactosylceramidase),µ¼Ö´úл¶¾ÎïPsychosine(PKCµÄÒÖÖÆ¼Á)ÔÚSchwannϸ°ûÄڶѼ¯,ʹϸ°û´úлÎÉÂÒ,·ÖÁÑÔöÉúÄÜÁ¦ºÜµÍ¡£ÎªÁ˽øÒ»²½Ö¤ÊµPKC»îÐÔ½µµÍÓëSchwannϸ°û¼õÉÙµÄÏà¹ØÐÔ,ËûÃÇÔÚ½¨Á¢´Ë¶¯ÎïÄ£Ð͵Ļù´¡ÉÏÊ©¼ÓPKCÒÖÖÆ¼ÁStaurosporine,·¢ÏÖ:Schwannϸ°ûµÄÉú³¤Ö»ÐèÒ»°ã´óÊóËùÐèStaurosporineŨ¶ÈµÄ1/10±ã¿ÉÒÔ±»ÒÖÖÆ£¬Òò¶ø,ËûÃÇÌá³ö:PKC¿ÉÄܲÎÓëSchwannϸ°ûµÄÔöÉú¡£½üÄêÀ´,»¹ÓÐһЩÑо¿±íÃ÷,PKC²»µ«²ÎÓëÁËPNËðÉ˺óSchwannϸ°ûµÄ·ÖÁÑÔöÖ³,¶øÇÒ»¹ÄÜͨ¹ý²»Í¬µÄϸ°ûÄÚ»úÖÆ²ÎÓëSchwannϸ°û²úÉú´ÙÖáÍ»Éú³¤·Ö×ÓµÄÉúÎïѧ¹ý³Ì£¬ÈçLamininÓÕµ¼Éñ¾­Í»ÆðÉú³¤±ØÐëÓлµÄPKC²ÎÓ룻ÒÖÖÆPKCµÄ»îÐÔ,±ãÒÖÖÆÁËÉñ¾­ÏËάÓëÏËάÁ¬½ÓËØ¡¢½ºÔ­µ°°×ºÍLaminin¼äµÄÏ໥×÷ÓõÈ[6]¡£

    ´ÓÒÔÉϵÄÑо¿ÖпÉÒÔ¿´³ö,PKCÔÚPNÔÙÉú¹ý³ÌÖз¢»ÓÁË¶à·½ÃæµÄ×÷Óá£Ëüͨ¹ý²»Í¬µÄ;¾¶Ö±½Ó»ò¼ä½ÓµØ²ÎÓëPNÔÙÉú£»Í¬Ê±,Ëü¶Ô·ÇÉñ¾­Ï¸°ûÈçSchwannϸ°û¹¦Äܵķ¢»ÓÒ²²úÉú·Ç³£ÖØÒªµÄÓ°Ïì¡£Éñ¾­ÔÙÉúÊǶàÖÖÒòËØ¹²Í¬²ÎÓë¡¢Ï໥Эµ÷µÄ½á¹û,Ëü×ñÑ­Ò»¶¨µÄ³ÌÐò²¢Í¨¹ý¾«Ï¸¸´Ôӵĵ÷¿Ø·½Ê½Íê³É¡£Òò´Ë,ŪÇåPKCÒÔ¼°ÐÅÏ¢´«µÝϵͳÆäËüÖØÒª»·½ÚÔÚPNÔÙÉúÖеĵ÷½Ú×÷ÓÃ,¶ÔÓÚ½ÒʾÉñ¾­ÔÙÉúµÄ·Ö×Ó»úÖÆ,½ø¶øÔÚÁÙ´²¹¤×÷ÖÐͨ¹ýÈ˹¤¸ÉÔ¤À´ÓÐЧµØ´Ù½øÉñ¾­ËðÉ˺óµÄÔÙÉúÓ빦ÄܵĻָ´,ÉõÖÁΪʵÏÖÖÐÊàÉñ¾­µÄÁ¼ºÃÔÙÉú,¶¼¾ßÓÐÊ®·ÖÖØÒªµÄÀíÂÛÒâÒå¼°Ó¦ÓÃǰ¾°¡£

    »ù½ðÏîÄ¿£º¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð×ÊÖúÏîÄ¿(39570373)

    ×÷Õß¼ò½é£ºÑî Æ¼£¬Å®£¬1967.02.24Éú£¬ËÄ´¨Ê¡ãÏÖÐÊÐÈË£¬ÔÚ¶Á²©Ê¿Éú£¬½²Ê¦£¬Ö÷Òª´ÓÊÂÖÜΧÉñ¾­ÔÙÉú·½ÃæµÄÑо¿¡£µç»°£º(023)68752225

    ×÷Õßµ¥Î»£ºµÚÈý¾üÒ½´óѧ»ù´¡Ò½Ñ§²¿½âÆÊѧ½ÌÑÐÊÒ£¬ÖØÇì400038

    ²Î¿¼ÎÄÏ×

    [1] Casabona g.Intracellular signal modulation:A pivotal role for protein kinase C[J]. prog Neuro Psychopharmacol Biol Psychiatry,1997£¬21(3):407-409.

    [2] Newton A C. Protein kinase C: Structure,function,and regulation[J].J biological Chemistry,1995£¬270(48):28495-28498.

    [3] Miki A. Expression of alpha-beta and gamma-subspecies of protein kinase C in the motor neurons in the embryonic and postnatal rat spinal cord[J]. neurosci,1996£¬72(3):805-808.

    [4] Okajima S, Mizoguchi A, Tamai K, et al.Distribution of protein kinase C(alpha,beta,gamma subtypes)in normal nerve fibers and in regeneration growth cones of the rat peripheral nervous system[J]. Neurosci,1995£¬66(3):645-648.

    [5] Kawano S, Okajima S, Mizoguchi A. Immunocytochemi-cal distribution of Ca2+-independent protein kinase C subtypes(¦Ä,¦Å,and ¦Æ)in regeneration axonal growth cones of rat peripheral nerve[J]. Neurosci£¬1997£¬81(1):263-266.

    [6] Bixby J L,Jhabvala P. Extracellular matrix molecules and cell adhesion molecules induce neurites through different mechanisms[J]. J Cell biol,1990£¬111(6,pt1):2725-2728.

    [7] Keynes R ,Cook G M. Axon guidance molecules[J]. Cell,1995£¬83(2):161-169.

    [8] Dent E W, Meiri K F. GAP-43 phosphorylation is dynamically regulated in individual growth cones[J]. J Neurobiology,1992£¬23(8):1037-1039.

    [9] Fan J, Raper J A. Localized collapsing cues can steer growth cones without inducing their full collapse[J]. Neuron,1995£¬14(2):263-274.

    [10] Rosner H, Fischer H. In growth cones of rat cerebral neurons and human neuroblastoma cells,activation of protein kinase C causes a shift from filopodial to lamellipodial actin dynamics[J]. Neurosci Lett,1996£¬219(3):175-178.

    [11] He Q, Dent E W, Meiri KF.Modulation of actin Filament behavior by gAP-43(Neuromodulin)is dependent on the phosphorylation status of serine 41,the protein kinase C site[J]. J Neurosci,1997£¬17(10):3515-3518.

    [12] Bush M S, Tonge D A, Woolf C, et al.Expression of a developmentally regulated phosphorylated isoform of microtubule-associated protein 1B in regenerating axons of the sciatic nerve[J]. Neurosci,1996£¬73(2):553-558.

    [13] Diaz-Nido J, Serrano L, Hernandez M, et al. Phosphorylation of microtubule protein in rat brain at different developmental stages:Comparison with that found in neuronal cultures[J]. J Neurochem,1990£¬54(1):211-214.

    [14] Xu X M. Roles of Schwann cells in the repair and regeneration of the central nervous system[J]. Chin J Neuroanatomy,1996£¬12(4):291-294.

    [15] Yoshimura T, Goda S, Kobayashi T, et al. Involvement of protein kinase C in the proliferation of cultured Schwann cells[J]. Brain Res,1993£¬617(1):55-58.

    [16] Yamada H, Martin P, Suzuki K.Impairment of protein kinase C activity in twitcher Schwann cells in vitro. Brain Res,1996£¬718(1¡«2):138-140.
Ïà¹ØÎÊ´ð£º
  • ¼¡Ëἤøͬ¹¦Ã¸¸ß44U/L£¬C-·´Ó¦µ°°×.
  • C·´Ó¦µ°°× ¸ß £¿£¿£¿£¿£¿£¿£¿£¿
  • ¼¹×µÉñ¾­¿ÉÒÔÔÙÉúÂð
  • ¿ìËÙC·´Ó¦µ°°×¹ý¸ß
  • ³¬Ãô£Ã·´Ó¦µ°°×³¬¸ß
  • c·´Ó³µ°°×+ÔõôÖÎÁÆ
  • C·´Ó¦µ°°×¸ß20.3
  • c·´Ó¦µ°°×¸ß£º141
  • c·´Ó¦µ°°×¼ÌÐøÉý¸ß
  • c·´Ó¦µ°°×ÈÔÔÚÉý¸ß
  • c·´Ó¦µ°°×¼ÌÐøÉý¸ß
  • C·´Ó¦µ°°×¸ßµÄÒâÒå

  • Ïà¹Ø×ÊѶ£º
  • µ°°×¼¤Ã¸C-¦ÄºÍ¸Æµ÷µ°°×¼¤Ã¸II-¦Ä(2.
  • C·´Ó¦µ°°×£¨CRP£©
  • ÖÜÎ§ÃæÉñ¾­Âé±ÔµÄÖÎÁÆ
  • ÌÇÄò²¡ÖÜΧÉñ¾­²¡±ä
  • ÌÇÄò²¡ÐÔÖÜΧÉñ¾­²¡±ä
  • ÌÇÄò²¡ÖÜΧÉñ¾­²¡±ä±íÏÖ
  • ÌÇÄò²¡ÐÔÖÜΧÉñ¾­²¡±ä
  • ÌÇÄò²¡ÖÜΧÉñ¾­²¡±ä
  • ÌÇÄò²¡ÐÔÖÜΧÉñ¾­²¡±ä
  • ÌÇÄò²¡ÖÜΧÉñ¾­²¡±ä±íÏÖ
  • ÌÇÄò²¡ÐÔÖÜΧÉñ¾­²¡±ä
  • C-·´Ó¦µ°°×ÓëÌåÖÊϽµÓйØ
  • ½¡¿µÍ¼Æ×

    ¼²²¡´óÈ«

    [½¡¿µ¹ºÎïºÃÈ¥´¦]½¡¿µÉ̳Ç
    ¾«²ÊÍÆ¼ö